Gene Editing
Overview
R&D Platforms
Manufacturing
Papers & Presentations
Our Pipeline
Our Pipeline
Ex Vivo
Therapies
In Vivo
Therapies
Our Focus
Genetic Diseases
Cancer
About Us
Company Overview
Scientific Founder
Leadership
Contact Us
Careers
Company Culture
Join Us
News
Press Releases
In the Media
简体中文
中文
Edit Code of Life,
Creating Transformative Solutions for Serious Human Diseases
Press Releases
In the Media
>
News
>
All
News
All
2023
2022
2021
2020
2019
2018
Search
07
2019-11
EdiGene to Present Data on Manufacturing Scale-up and Preclinical Development of its Leading Gene Editing Therapeutic Program to Treat Patients with β-Thalassemia Major
LEARN MORE
28
2019-10
Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio
LEARN MORE
28
2019-10
Genome Editing Biotech EdiGene Raises $11 M in Series Pre-B2 Financing and Forms Research Collaboration to Develop Allogeneic T-cell Therapeutics for Cancer
LEARN MORE
18
2019-07
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
LEARN MORE
03
2019-04
EdiGene Announced Strategic Collaboration with Genetron
LEARN MORE
13
2019-02
Genome Editing Biotech EdiGene Raises $10 Million in Series pre-B Plus Financing and Strengthens Management Team
LEARN MORE
10
2018-08
Genome Editing Biotech EdiGene Names Dong Wei, Ph.D., MBA as its Chief Executive Officer
LEARN MORE
08
2018-08
Genome Editing Biotech EdiGene Raises $15 Million in Series pre-B Financing
LEARN MORE
1
2
3
4
